Why the study?
To determine an MR-proADM value that identifies patients with localized infection, sepsis or septic shock, specific organ damage, need for ICU transfer, and prognosis, and to correlate it with length of stay.
Does mid-regional pro-adrenomedullin (MR-proADM) predict organ failure and prognosis in patients with sepsis or localized infection?
Population
301 subjects with sepsis (124/301 with septic shock) and 126 with localized infection
Comparison
MR-proADM levels across clinical severities, organ failures, and outcomes
Design
Retrospective study
Authors
Loading...
MR-proADM cutoffs may aid sepsis severity assessment; leaves open prospective validation before guiding ICU decisions.
Does mid-regional pro-adrenomedullin (MR-proADM) predict organ failure and prognosis in patients with sepsis or localized infection?
MR-proADM is a valuable biomarker that reflects oxidative stress and correlates proportionally with organ damage severity, ICU admission need, and mortality in sepsis.
Spoto et al. (2023) studied this question.